8-K

Gen Digital Inc. (GEN)

8-K 2022-05-03 For: 2022-05-03
View Original
Added on April 06, 2026

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of the

Securities

Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): May3, 2022


NortonLifeLock Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware 000-17781 77-0181864
(State<br> or Other Jurisdiction of <br><br> Incorporation) (Commission<br> File Number) (IRS<br> Employer Identification No.)
60 E. Rio Salado Parkway**, Suite 1000** , Tempe , AZ 85281
--- ---
(Address<br> of Principal Executive Offices) (Zip<br> Code)

Registrant’s

Telephone Number, Including Area Code (650) 527-8000

(Former name or former address, if

changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol Name of each exchange on which registered
Common Stock, par value $0.01 per share NLOK The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01 Other Events.

On May 3, 2022, NortonLifeLock Inc. (the “Company”) announced that a federal jury awarded Columbia University more than $185 million in damages after finding that NortonLifeLock Inc. infringed two patents related to cybersecurity safeguards. A copy of the Company’s announcement is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit Number Description of Document
99.01 Announcement
104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NortonLifeLock Inc.
Date: May 3, 2022 By: /s/ Bryan S. Ko
Bryan S. Ko<br><br> <br>Chief Legal Officer and Corporate<br><br> Secretary

Exhibit99.01


NortonLifeLockto challenge jury verdict on SONAR/BASH behavior protection technology

Tempe, AZ, May 3, 2022:  NortonLifeLock Inc. (NASDAQ: NLOK) announced today that the jury returned its verdict in a patent infringement case filed in 2013 by the Trustees of Columbia University in the City of New York in the U.S. District Court for the Eastern District of Virginia. The jury found that NortonLifeLock’s Norton Security products and Symantec Endpoint Protection products (the latter of which were sold to Broadcom as part of an Asset Purchase Agreement with NortonLifeLock dated November 4, 2019) willfully infringe Columbia’s U.S. Patent Nos. 8,601,322 and 8,074,115 through the use of SONAR/BASH behavioral protection technology.  The jury awarded damages in the amount of $185,112,727 plus interest.  The awarded damages may also be subject to enhancement from the Court.  Columbia did not seek injunctive relief against NortonLifeLock. NortonLifeLock intends to cease use of the technology found by the jury to infringe.

The jury also found that NortonLifeLock did not fraudulently conceal its prosecution of U.S. Patent No. 8,549,643 but did find that two Columbia professors were coinventors of this patent.  No damages were awarded related to this patent.

A formal judgment has not yet been entered in the case.  There are likely to be post-verdict motions and hearings, and NortonLifeLock intends to file an appeal challenging the verdict.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that do not represent historical facts and may be based on underlying assumptions. NortonLifeLock uses words and phrases such as “intends”, “likely to be” and similar expressions to identify forward-looking statements in this announcement. Such forward-looking statements are based on information available to NortonLifeLock as of the date of this announcement and involve a number of risks and uncertainties, some beyond NortonLifeLock’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. These forward-looking statements should not be relied upon as representing NortonLifeLock’s views as of any subsequent date, and NortonLifeLock is under no obligation to, and expressly disclaims any responsibility to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.